These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25007361)

  • 41. Topical acyclovir in the management of recurrent herpes labialis.
    Fiddian AP; Ivanyi L
    Br J Dermatol; 1983 Sep; 109(3):321-6. PubMed ID: 6351894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized, double-blind, placebo-controlled study to test the efficacy of topical 2-hydroxypropyl-Beta-cyclodextrin in the prophylaxis of recurrent herpes labialis.
    Senti G; Iannaccone R; Graf N; Felder M; Tay F; Kündig T
    Dermatology; 2013; 226(3):247-52. PubMed ID: 23816977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical comparison of two topical antiviral ointments in herpes].
    Makleit L; Nagy M
    Orv Hetil; 1995 Feb; 136(8):417-9. PubMed ID: 7885687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Failure of acyclovir cream in treatment of recurrent herpes labialis.
    Shaw M; King M; Best JM; Banatvala JE; Gibson JR; Klaber MR
    Br Med J (Clin Res Ed); 1985 Jul; 291(6487):7-9. PubMed ID: 3926067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis.
    Koytchev R; Alken RG; Dundarov S
    Phytomedicine; 1999 Oct; 6(4):225-30. PubMed ID: 10589440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis.
    Hull CM; Brunton S
    Postgrad Med; 2010 Sep; 122(5):1-6. PubMed ID: 20873400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent approval of Xerese in Canada: 5% acyclovir and 1% hydrocortisone topical cream in the treatment of herpes labialis.
    Nguyen HP; Stiegel KR; Downing C; Stiegel KR
    Skin Therapy Lett; 2014; 19(3):5-8. PubMed ID: 25188362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: A double-blind, dose-ranging, placebo-controlled, multicenter trial.
    Spruance SL; Rowe NH; Raborn GW; Thibodeau EA; D'Ambrosio JA; Bernstein DI
    J Infect Dis; 1999 Feb; 179(2):303-10. PubMed ID: 9878012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies.
    Spruance SL; Jones TM; Blatter MM; Vargas-Cortes M; Barber J; Hill J; Goldstein D; Schultz M
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1072-80. PubMed ID: 12604544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialis.
    Formica M; Kabbara K; Clark R; McAlindon T
    J Med Internet Res; 2004 Feb; 6(1):e6. PubMed ID: 15111272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recurrent herpes labialis: efficacy of topical therapy with penciclovir compared with acyclovir (aciclovir).
    Femiano F; Gombos F; Scully C
    Oral Dis; 2001 Jan; 7(1):31-3. PubMed ID: 11354919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Herpes labialis treatment with acyclovir 5 per cent ointment.
    Raborn GW; McGaw WT; Grace M; Houle L
    J Can Dent Assoc; 1989 Feb; 55(2):135-7. PubMed ID: 2645030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful treatment of herpes labialis with topical acyclovir.
    Fiddian AP; Yeo JM; Stubbings R; Dean D
    Br Med J (Clin Res Ed); 1983 May; 286(6379):1699-701. PubMed ID: 6405939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Herpes labialis in skiers: randomized clinical trial of acyclovir cream versus placebo.
    Raborn GW; Martel AY; Grace MG; McGaw WT
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Dec; 84(6):641-5. PubMed ID: 9431533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial.
    Engström M; Berg T; Stjernquist-Desatnik A; Axelsson S; Pitkäranta A; Hultcrantz M; Kanerva M; Hanner P; Jonsson L
    Lancet Neurol; 2008 Nov; 7(11):993-1000. PubMed ID: 18849193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pragmatic and Profound Benefits of Acyclovir Buccal Adhesive Tablets.
    Rosen T
    J Drugs Dermatol; 2016 Jun; 15(6):775-7. PubMed ID: 27272090
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of recurrent herpes simplex labialis with oral acyclovir.
    Spruance SL; Stewart JC; Rowe NH; McKeough MB; Wenerstrom G; Freeman DJ
    J Infect Dis; 1990 Feb; 161(2):185-90. PubMed ID: 2153735
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study.
    Lawee D; Rosenthal D; Aoki FY; Portnoy J
    CMAJ; 1988 Feb; 138(4):329-33. PubMed ID: 2962712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of herpes labialis with acyclovir. Review of three clinical trials.
    Raborn GW; McGaw WT; Grace M; Percy J
    Am J Med; 1988 Aug; 85(2A):39-42. PubMed ID: 3044091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Valaciclovir as a single dose during prodrome of herpes facialis: a pilot randomized double-blind clinical trial.
    Chosidow O; Drouault Y; Garraffo R; Veyssier P;
    Br J Dermatol; 2003 Jan; 148(1):142-6. PubMed ID: 12534609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.